OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association of SGLT2 inhibitors with lower incidence of death in type 2 diabetes mellitus and causes of death analysis
Mu‐Chi Chung, Hui‐Tsung Hsu, Chao‐Hsiang Chang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Mu‐Chi Chung, Hui‐Tsung Hsu, Chao‐Hsiang Chang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Sodium-glucose cotransporter-2 inhibitors and cancer outcomes: A systematic review and meta-analysis of randomized controlled trials
Bernardo Frison Spiazzi, Rafaella A. Naibo, Laura Fink Wayerbacher, et al.
Diabetes Research and Clinical Practice (2023) Vol. 198, pp. 110621-110621
Closed Access | Times Cited: 21
Bernardo Frison Spiazzi, Rafaella A. Naibo, Laura Fink Wayerbacher, et al.
Diabetes Research and Clinical Practice (2023) Vol. 198, pp. 110621-110621
Closed Access | Times Cited: 21
Sodium‐glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new‐onset overall cancer in Type 2 diabetes mellitus: A population‐based study
Cheuk To Chung, Ishan Lakhani, Oscar Hou In Chou, et al.
Cancer Medicine (2023) Vol. 12, Iss. 11, pp. 12299-12315
Open Access | Times Cited: 15
Cheuk To Chung, Ishan Lakhani, Oscar Hou In Chou, et al.
Cancer Medicine (2023) Vol. 12, Iss. 11, pp. 12299-12315
Open Access | Times Cited: 15
Utilizing shared frailty with the Cox proportional hazards regression: Post discharge survival analysis of CHF patients
Ofir Ben‐Assuli, Roni Ramon‐Gonen, Tsipi Heart, et al.
Journal of Biomedical Informatics (2023) Vol. 140, pp. 104340-104340
Open Access | Times Cited: 5
Ofir Ben‐Assuli, Roni Ramon‐Gonen, Tsipi Heart, et al.
Journal of Biomedical Informatics (2023) Vol. 140, pp. 104340-104340
Open Access | Times Cited: 5
Treatment with SGLT2 Inhibitors in Patients with Diabetes Mellitus and Extensive Coronary Artery Disease: Mortality and Cardiovascular Outcomes
David Chipayo-Gonzales, Asad Shabbir, Carlos E. Vergara-Uzcategui, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 11, pp. 1853-1865
Open Access | Times Cited: 5
David Chipayo-Gonzales, Asad Shabbir, Carlos E. Vergara-Uzcategui, et al.
Diabetes Therapy (2023) Vol. 14, Iss. 11, pp. 1853-1865
Open Access | Times Cited: 5
Sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists and cancer mortality. A real-world registry
David García‐Vega, Sergio Cinza‐Sanjurjo, Carlos Tilves-Bellas, et al.
Revista Española de Cardiología (English Edition) (2024)
Open Access
David García‐Vega, Sergio Cinza‐Sanjurjo, Carlos Tilves-Bellas, et al.
Revista Española de Cardiología (English Edition) (2024)
Open Access
Pharmacological Manipulation of the Aging Pathways to Effect Health Span and Lifespan with Special Reference to SGLT2 Inhibitors as Powerful Anti-aging Agents in Humans
M. K.
Insights in Biology and Medicine (2024) Vol. 8, Iss. 1, pp. 011-025
Open Access
M. K.
Insights in Biology and Medicine (2024) Vol. 8, Iss. 1, pp. 011-025
Open Access
Sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new-onset overall cancer in type 2 diabetes mellitus: a population-based study
Cheuk To Chung, Ishan Lakhani, Oscar Hou In Chou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
Cheuk To Chung, Ishan Lakhani, Oscar Hou In Chou, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 2
